Clinical trials
Phase 1 Urogenital Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 2 |
| 2011 | 1 |
| 2014 | 1 |
| 2015 | 6 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 3 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Active, not recruiting | 7 |
| Terminated | 5 |
| Recruiting | 4 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 3 |
| Celldex Therapeutics | 2 |
| M.D. Anderson Cancer Center | 2 |
| Mayo Clinic | 2 |
| Advanced Accelerator Applications | 1 |
| Advaxis, Inc. | 1 |
| AgonOx, Inc. | 1 |
| Aragon Pharmaceuticals, Inc. | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| Atavistik Bio, Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urogenital Neoplasms | 26 |
| Neoplasms | 13 |
| Prostatic Neoplasms | 12 |
| Breast Neoplasms | 9 |
| Neoplasms by Site | 8 |
| Prostatic Diseases | 8 |
| Genital Neoplasms, Male | 7 |
| Melanoma | 6 |
| Ovarian Neoplasms | 6 |
| Carcinoma, Renal Cell | 5 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.